Skip to main content Skip to search Skip to main navigation

Water Qualities – Purified Water

Excerpt from the GMP Compliance Adviser, Chapter 5.A.3: Purified water

5 min. reading time | by Fritz Röder
Published in LOGFILE 09/2025

Pharmaceutical water occupies a unique position within the pharmaceutical industry. Whereas raw materials and excipients are used only after quality control and approval, pharmaceutical water is used immediately after production. For this reason, it is considered extremely critical. Three types of water are of particular importance: potable source water, purified water (PW) and water for injection (WFI). In this issue we will focus on PW, while a future issue of LOGFILE will cover WFI.

Stay up to date on water quality by exploring Chapter 5.A: Water Qualities in your GMP Compliance Adviser, the world's most comprehensive online GMP knowledge portal.


Production and use

Demineralised water, deionised water, pure water or aqua purificata are commonly used for purified water. When choosing a process, technologies such as reverse osmosis (RO) are described, but in principle the pharmaceutical manufacturer is free to choose.

Because the requirements (in Germany) for microbiological purity of purified water are no stricter than those that apply to drinking water (max. 100 CFU/ml), simple ion exchanger systems are still used, especially in very large facilities. Modern manufacturing processes, however, normally use membrane technology for desalination. Depending on the initial salt content, a second membrane stage or downstream electrochemical desalination may be necessary to achieve the required desalination.

In accordance with the Pharmacopoeia, purified water in bulk can be used during the manufacture of preparations that do not have to be sterile or free of pyrogens. Tablets, capsules, ointments, lotions or nasal sprays are typical dosage forms. Purified water is often used as a starting material for the manufacture of water for injections.

In accordance with the Pharmacopoeia, purified water in bulk can be used during the manufacture of preparations that do not have to be sterile or free of pyrogens. Tablets, capsules, ointments, lotions or nasal sprays are typical dosage forms. Purified water is often used as a starting material for the manufacture of water for injections.

Quality requirements

The European Pharmacopoeia (Ph. Eur.) and the United States Pharmacopeia (USP) both stipulate the test parameters and acceptance limits shown in Figure 1. Limit values can always be found directly in the monographs in the European Pharmacopoeia. The United States Pharmacopeia, however, refers the reader to the relevant General Chapter.

Tabelle 1

Figure 1        Requirements for purified water in bulk


Microbiological monitoring

The specified action level for purified water in the European Pharmacopoeia is 100 CFU/ml. In practice, however, this limit appears to be understood as a specification rather than an action limit. The monograph also includes precise information on:

  •     The performance of the test (maximum membrane filtration of 0.45 µm)
  •     The agar to be used (only Ph. Eur. R2A agar)
  •     The incubation conditions (a minimum of 5 days at 30 to 35 °C)
  •     The test bacteria to be used for the culture media tests

These incubation conditions were chosen at the time as a compromise between incubation period (business risk) and recovery (quality risk). This compromise has also proven itself in practice. Drinking water germs are incubated at two temperatures (22 °C and 36 °C), germs in ultrapure water only at one temperature (30–35 °C). An incubation period of more than five days would cause problems in production, because many manufacturers already produce their bulk or finished products "at risk" until the water results are available. Longer incubation times would only further increase the economic risks in manufacturing. 

The European Pharmacopoeia specifies a "suitable" volume as the volume to be filtered. In contrast to WFI, only small volumes can be filtered here to obtain results that can still be counted.

The United States Pharmacopeia contains recommendations on the general implementation of the incubation (see USP <1231>); however, the expectation is that the pharmaceutical manufacturer specifies the absence of defined microorganisms based on a risk assessment and designs a suitable method of incubation. The volume to be filtered is specified as "up to 100 ml".

Neither pharmacopoeia explicitly claims for testing for specified microorganisms. However, it is practically impossible to escape an observation in the course of a regulatory inspection without providing information on particular bacteria types. Proof of the absence of Ps. aeruginosa and E. coli in 100 ml is often expected by the authorities ("exclusion germs"). This requirement makes sense, but it should be noted that it is not stipulated in the regulations.

For drinking water E. coli is already defined as an exclusion germ. Thus, one could expect (in case of a negative result) that the feed water of the PW system is free of E. coli. Nevertheless, it may be useful to test purified water for E. coli at production tapping points to monitor the general hygiene status in the manufacturing plant. Positive findings at sampling points indicate improper handling or inadequate industrial hygiene, but not a biofilm in the water system. Of the species listed in Ph. Eur. 2.6.13 and USP <62>, Pseudomonas aeruginosa is the only one that is viable in ultrapure water and is therefore preferred in practice.

For certain applications and depending on the quality of water treatment, additional measures to reduce the microbial count may be necessary when storing purified water. If purified water is used as autoclave cooling water in direct contact with the containers, significantly stricter limit values should be established. Guidance on this can be found in the EMA Guideline on the sterilisation of the medicinal product, active substance, excipient and primary container, which specifies requirements depending on the application.


Determining conductivity

Both pharmacopoeias also contain a detailed description of conductivity measurement (Ph. Eur. 2.2.38, USP <645>). Measuring devices with defined technical requirements are specified for determining conductivity (on-line or off-line). The cell constant of the conductivity cell must be certified by the supplier and regularly calibrated using a certified reference solution or a conductivity cell with a certified cell constant. Additional requirements include system calibration with an accuracy of ±2 % (USP <645>) and calibration of the conductometer. The maximum deviation permitted during temperature measurement is ±2 °C. The European water quality requirements are considered met when the values listed in Figure 2 are not exceeded at the given temperatures.

Tabelle 2

Figure 2        Temperature and conductivity of purified water (European Pharmacopoeia, 10.6, 2021)


Elemental impurities

If the conductivity of the purified water does not correspond to the equivalent requirements for Water for Injections (i.e. 1.3 µS/cm at 25°C), a risk assessment according to general chapter 5.20 Elemental impurities is carried out. The risk assessment should consider the role of water in the manufacturing process, when water is used in a process but is no longer present in the final product.

This requirement was introduced in Ph. Eur. 9.4 and replaces the former test for heavy metals.


Purified water in containers

Purified water that has been filled into containers for dispensing is a final product. Additional purity testing must be carried out. The specifications in the "Purified water in containers" pharmacopoeia monograph then apply. This product may not contain additives and must pass the purity tests for "Purified water in bulk" and the following tests:

  • Acidity or alkalinity
  • Oxidisable substances
  • Chlorides
  • Sulfates
  • Ammonium
  • Calcium and magnesium
  • Residue on evaporation
  • Microbial contamination

In addition, the liquid should be clear and colourless.

The microbial purity is specified at 100 CFU/ml. It is determined using casein soya bean digest agar.

The USP also specifies sterile purified water. This water must meet the specifications for sterility in addition to the chemical/physical parameters.

 


Do you have any questions or suggestions? Please contact us at: redaktion@gmp-verlag.de

Fritz Röder
Fritz Röder

You may also be interested in the following articles:

How is a QRM process initiated?

How is a QRM process initiated?

You can view the answer here:
Read more
FDA: Updated Pre-RFD Guidance for Combination Products

FDA: Updated Pre-RFD Guidance for Combination Products

The U.S. FDA has released an updated final guidance on preparing a Pre-Request for Designation (Pre-RFD), replacing the previous 2018 version. The revised document provides new recommendations for interacting with the Office of Combination Products (OCP) and clarifies expectations for Pre-RFD submissions.
Read more
EDQM: 9 Virtual Training Modules on Ph. Eur. and CEPs

EDQM: 9 Virtual Training Modules on Ph. Eur. and CEPs

The EDQM has introduced a modular training programme covering chemically defined active substances and medicinal products. It will take place between 1 and 12 December 2025.
Read more
Previous
Next

Related Products

Skip product gallery
GMP Compliance Adviser | Named User Licence | 12M

GMP Compliance Adviser | Named User Licence | 12M

The GMP Compliance Adviser is an online publication that covers all aspects of Good Manufacturing Practice (GMP) in one source.In the GMP Compliance Adviser you’ll find: GMP in Practice This part contains 21 chapters with GMP expert knowledge to base your decisions upon. It provides practical assistance with checklists, templates and SOP examples. It is written by more than 80 authors with hands-on experience directly linked to the industry. The individual chapters describe the different aspects of GMP in clear language. Technical, organizational and procedural aspects are covered.More than 700 checklists, templates and examples of standard operation procedures taken directly out of practice help you in understanding the GMP requirements.GMP RegulationsThese chapters cover the most important GMP regulations from Europe and the United States (CFR and FDA), but also PIC/S, ICH, WHO and many more.  Sample Documents In addition, the GMP Compliance Adviser contains many sample documents and practical examples that you can use.

Ready for dispatch, Delivery time appr. 2-5 workdays (2-3 weeks for christmas goodies)
€1,335.00 net excl. VAT
GMP:KnowHow Pharma Logistics (GDP) | Named User License | 12M

GMP:KnowHow Pharma Logistics (GDP) | Named User License | 12M

Your knowledge base about GDP-compliant handling of your pharmaceutical logistics. It is important that you as a logistics service provider, but also as a client in the pharmaceutical industry, adhere precisely to the regulatory requirements. The GMP:KnowHow knowledge portal guides you through the regulatory jungle of the pharmaceutical and logistical supply chain! The knowledge portal gives you an easy-to-understand overview of all the important topics. Using graphics, you can easily navigate through all the areas covered by the EU GDP Guidelines (2013/C 343/01). You also have the relevant passages of the regulations directly at hand for each topic. This allows you to compare the requirements directly and saves you a lot of time on time-consuming searches and research!One thing is certain: the knowledge portal answers your questions about the supply chain of medicinal products, active pharmaceutical ingredients and medical devices. You don't have to be an expert. Yet.You will find answers to your questions in the GMP:KnowHow Pharma Logistics (GDP). Where does GDP begin, where does GMP end? What does GDP-compliant mean? When do I also have to take GMP requirements into account? What permits do I need for certain activities? What requirements do I have to fulfil? What is the current legal basis? How am I covered? What authorizations do I have for my work, e.g. from my employer? Who is responsible — the client or the contractor? And many more What is the difference to the GMP Compliance Adviser? The GMP:KnowHow Pharma Logistics (GDP) is your guideline for Good Distribution Practice. It is a product that is independent of the GMP Compliance Adviser and concentrates on content that is essential for carriers of medicinal products, active pharmaceutical ingredients and medical devices as well as for logistics clients. The focus is on practical knowledge and how to apply it in your daily business. If necessary, the relevant regulations can be called up immediately alongside the practical knowledge, and you can see the relevant paragraphs at a glance. In addition, sample documents are available to help you make immediate progress. AuthorSimone Ferrante – now Director Quality at Fisher Clinical Services – was previously Head of Quality Control and Responsible Person according to GDP (VP) for the entire Grieshaber Group. She is also a long-standing author and GDP expert at GMP-Verlag.

Ready for dispatch, Delivery time appr. 2-5 workdays (2-3 weeks for christmas goodies)
€610.00 net excl. VAT
E-Learning GMP:READY | GMP for Engineers Online Course

E-Learning GMP:READY | GMP for Engineers Online Course

Why are GMP rules important for technicians and engineers? Technicians and engineers play a key role in ensuring compliance with Good Manufacturing Practice (GMP) standards. They are involved in critical activities such as: planning and construction of ventilation systems, maintenance of water treatment plants, calibration of measuring sensors. Therefore, they are jointly responsible for the quality of medicines and must ensure that their work complies with GMP standards.Your advantages: Fast familiarization with GMP topics in approx. 2 hours, time- and location-independent online training, printable personal certificate, 12-month access for initial and follow-up training, automatic updates in case of legal changes, content compliant with Article 7(4) of Directive 2003/94/EC.

Ready for dispatch, Delivery time appr. 2-5 workdays (2-3 weeks for christmas goodies)
€240.00 net excl. VAT
GMP Fundamentals | A Step-by-Step Guide

GMP Fundamentals | A Step-by-Step Guide

This handbook is a practical and easy to read guideline, giving you a quick and comprehensive overview of the complex world of Good Manufacturing Practice (GMP) without the need of previously acquired knowledge. Some topics are: GMP: Purpose and basic pharmaceutical terms Laws, licenses and inspections Personnel: Responsibility and hygiene Standard Operating Procedures (SOP) and documentation Design of rooms and facilities Processing and packaging Quality control and market release Suppliers, storage and logistics (Good Distribution Practice = GDP) Alphabetical index and abbreviations Using practical examples and comparisons to every-day life will help to easy understand GMP regulations.GMP Fundamentals is a helpful guide which facilitates the entry into the GMP world and teaches the necessary basics.

Ready for dispatch, delivery immediately after receipt of payment
€44.90 net excl. VAT